{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:27:43Z","timestamp":1787315263957,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jaip.2018.02.032","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T20:29:40Z","timestamp":1521577780000},"page":"1198-1204.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature"],"prefix":"10.1016","volume":"6","author":[{"given":"Igor","family":"Snast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Lapidoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes David","family":"Enk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossi","family":"Rosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Confino-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmilia","family":"Hodak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assi","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.02.032_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.iac.2013.09.010","article-title":"Physical urticarias and cholinergic urticaria","volume":"34","author":"Abajian","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.02.032_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000246570","article-title":"Detection of action, inhibition and augmentation spectra in solar urticaria","volume":"191","author":"Miyauchi","year":"1995","journal-title":"Dermatol Basel Switz"},{"key":"10.1016\/j.jaip.2018.02.032_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archderm.144.6.765","article-title":"Synergistic effect of broad-spectrum sunscreens and antihistamines in the control of idiopathic solar urticaria","volume":"144","author":"Faurschou","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0781.1997.tb00109.x","article-title":"Cyclosporin A therapy for severe solar urticaria","volume":"13","author":"Edstr\u00f6m","year":"1997","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaip.2018.02.032_bib5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.7150\/thno.18304","article-title":"Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of Fc\u03b5RI-positive cells in the skin","volume":"7","author":"Metz","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jaip.2018.02.032_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2017.06.032","article-title":"Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence","volume":"141","author":"Maurer","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.02.032_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/phpp.12186","article-title":"Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity","volume":"31","author":"Levi","year":"2015","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaip.2018.02.032_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaip.2014.07.008","article-title":"Dissociation between history and challenge in patients with physical urticaria","volume":"2","author":"Komarow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.02.032_bib9","first-page":"109","article-title":"Photodermatoses\u2014diagnostic procedures and their interpretation","volume":"4","author":"H\u00f6lzle","year":"1987","journal-title":"Photodermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2011","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jaip.2018.02.032_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaip.2017.10.001","article-title":"The urticaria activity score-validity, reliability, and responsiveness","volume":"6","author":"Hawro","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.02.032_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaad.2015.11.021","article-title":"Omalizumab in patients with severe and refractory solar urticaria: a phase II multicentric study","volume":"74","author":"Aubin","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib13","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1097\/PRS.0b013e3181f44abc","article-title":"Observational studies: cohort and case-control studies","volume":"126","author":"Song","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaip.2018.02.032_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/pai.12441","article-title":"Successful omalizumab treatment of severe solar urticaria in a 6-year-old child","volume":"26","author":"Levi","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"Suppl S1","key":"10.1016\/j.jaip.2018.02.032_bib15","first-page":"90","article-title":"The use of omalizumab in three patients with solar urticaria: pd03","volume":"173","author":"Sivaramakrishnan","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000320233","article-title":"Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria","volume":"154","author":"Metz","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.02.032_bib17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/bjd.14540","article-title":"Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients","volume":"175","author":"Ghazanfar","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.anai.2015.12.023","article-title":"Effectiveness of omalizumab in severe solar urticaria","volume":"116","author":"de Dios-Vel\u00e1zquez","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.02.032_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0781.2011.00624.x","article-title":"Failure of omalizumab (Xolair\u00ae) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light","volume":"27","author":"Duchini","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaip.2018.02.032_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/ced.13173","article-title":"Long-term management of chronic spontaneous urticaria with omalizumab","volume":"42","author":"Pinto Gouveia","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaci.2009.11.007","article-title":"Partial improvement of solar urticaria after omalizumab","volume":"125","author":"Waibel","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.02.032_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00105-016-3913-0","article-title":"[Partial response of solar urticaria to omalizumab therapy]","volume":"68","author":"Kowalzick","year":"2017","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaip.2018.02.032_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ad.2016.11.015","article-title":"Refractory solar urticaria successfully treated with omalizumab with normalization of phototest","volume":"108","author":"Combalia","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaip.2018.02.032_bib24","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.ad.2016.08.011","article-title":"Response to omalizumab in solar urticaria: report of 3 cases","volume":"108","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaip.2018.02.032_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamadermatol.2013.8705","article-title":"Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria","volume":"150","author":"Metz","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/ced.12951","article-title":"Solar urticaria induced by visible light: successful treatment with omalizumab","volume":"41","author":"Terrani","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1398-9995.2008.01879.x","article-title":"Successful treatment of solar urticaria with anti-immunoglobulin E therapy","volume":"63","author":"G\u00fczelbey","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.02.032_bib28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/ddg.13017","article-title":"Successful treatment of solar urticaria with omalizumab","volume":"14","author":"Br\u00fcning","year":"2016","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2018.02.032_bib29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jdv.13001","article-title":"Three cases of solar urticaria successfully treated with omalizumab","volume":"30","author":"Baliu-Piqu\u00e9","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.02.032_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pai.12413","article-title":"Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria","volume":"26","author":"Arasi","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.02.032_bib31","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bjd.14354","article-title":"Unique coexistence of cold and solar urticaria and its efficient treatment","volume":"174","author":"Zimmer","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/phpp.12271","article-title":"Visible light-induced solar urticaria is improved by omalizumab","volume":"32","author":"Moncourier","year":"2016","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaip.2018.02.032_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2013.08.011","article-title":"Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis","volume":"73","author":"Metz","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2018.02.032_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jdv.12922","article-title":"Failure of omalizumab in the treatment of solar urticaria","volume":"30","author":"M\u00fcller","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2018.02.032_bib35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA(2) LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.02.032_bib36","first-page":"S1","article-title":"A\u00a0summary of the New International EAACI\/GA(2)LEN\/EDF\/WAO Guidelines in Urticaria","volume":"5","author":"Zuberbier","year":"2012","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2018.02.032_bib37","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2340\/00015555-2140","article-title":"No major effect of cyclosporin A in patients with severe solar urticaria: a French retrospective case series","volume":"95","author":"Hurabielle","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2018.02.032_bib38","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaad.2014.07.023","article-title":"Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study","volume":"71","author":"Aubin","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.02.032_bib39","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jaci.2015.12.1342","article-title":"Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials","volume":"137","author":"Zhao","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:16:55Z","timestamp":1761974215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213219818301326"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.02.032","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}